Amori, Gulanbar
Sugawara, Emiko
Shigematsu, Yasuyuki
Akiya, Masashi
Kunieda, Junko
Yuasa, Takeshi
Yamamoto, Shinya
Yonese, Junji
Takeuchi, Kengo
Inamura, Kentaro http://orcid.org/0000-0001-6444-3861
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (19K07426)
Takeda Science Foundation
Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Suzuki Foundation for Urological Medicine
Article History
Received: 15 September 2020
Revised: 6 January 2021
Accepted: 20 January 2021
First Online: 8 February 2021
Compliance with ethical standards
:
: KI received research grants from Konica Minolta, Inc. and Daiichi Sankyo Co., Ltd. TY received remuneration for a lecture from Astellas, Sanofi Japan, Pfizer Japan, Novartis Pharma Japan, Ono Pharma, Bristol-Myers Squibb Japan, and Daiichi Sankyo. All other authors declare no conflict of interest.
: This study was performed with the approval of the institutional review board of Japanese Foundation for Cancer Research (ethic code: 2018-1177). All patients included in this study provided informed consent for the research. This study was performed in accordance with the Declaration of Helsinki.